Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Sandra Ramos-Alves | F | - | 2 Jahre | |
| Christopher Boerner | M | 53 | 9 Jahre | |
| Phil Holzer | M | 48 | 11 Jahre | |
| Jason Brown | M | 37 | 6 Jahre | |
| Alexis Smith | F | - | 1 Jahre | |
| Deepak Bhatt | M | 56 | 2 Jahre | |
| Karen Vousden | M | 66 | 6 Jahre | |
| Benjamin Hickey | M | 50 | 4 Jahre | |
| Phyllis Yale | F | 66 | 5 Jahre | |
| Adam Levy | M | - | 3 Jahre | |
| Sophia Park | F | - | - | |
| Raymond Furey | M | 56 | - | |
| Manuel Hidalgo Medina | M | 56 | 3 Jahre | |
| Scott Lipman | M | - | 4 Jahre | |
| Cari Gallman | F | - | - | |
| MARIA V BRESNAHAN | M | - | 2 Jahre | |
| Julia Haller | M | 69 | 5 Jahre | |
| Sandra Leung | F | 63 | 32 Jahre | |
| Theodore Samuels | M | 69 | 7 Jahre | |
| Peter Arduini | M | 59 | 8 Jahre | |
| Derica Rice | M | 59 | 4 Jahre | |
| Konstantina Katcheves | F | - | - | |
| Laura Hortas | F | - | - | |
| Mark Rolfe | M | - | 5 Jahre | |
| Paula Price | F | 62 | 4 Jahre | |
| David Elkins | M | 55 | 5 Jahre | |
| Louis Schmukler | M | - | 13 Jahre | |
| Douglas Cowart | M | - |
Cardioxyl Pharmaceuticals LLC
 Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | 19 Jahre |
| Michael Givertz | M | - |
Cardioxyl Pharmaceuticals LLC
Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | - |
| Naseem Zojwalla | M | 51 | - | |
| Greg Meyers | M | - | - | |
| Ronald Borchardt | M | - |
Cardioxyl Pharmaceuticals LLC
Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | - |
| Katherine Reynolds Kelly | F | 48 | - | |
| Cynthia Piccirillo | F | - | - | |
| William Perhacs | M | - | 17 Jahre | |
| Zack Newman | M | - | 11 Jahre | |
| Monica Shaw | M | 46 | 1 Jahre | |
| Estelle Vester-Blokland | F | - | - | |
| Yi Liu Kai | F | - |
Bristol-Myers Squibb FCT bêta, Inc.
 Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | 3 Jahre |
| Adam Lenkowsky | M | - | - | |
| Krisztina Nemenyi | M | - | - | |
| Brian Sun | M | 40 | 2 Jahre | |
| Jeff Bank Clark | M | 67 |
Cardioxyl Pharmaceuticals LLC
Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | - |
| Naresh K. Nayyar | M | - | 6 Jahre | |
| Shi Yin Foo | M | - |
Cardioxyl Pharmaceuticals LLC
Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | 11 Jahre |
| Ed Gemo | M | - | - | |
| Catalina Vargas | F | - | - | |
| Jonathan Biller | M | 61 | - | |
| Nina Goworek | F | - | 6 Jahre | |
| Gavin Hirst | M | - | 4 Jahre | |
| Samit Hirawat | M | 55 | 5 Jahre | |
| Miriam Cruz | F | - | 6 Jahre | |
| Kyri van Hoose | M | - | 3 Jahre | |
| Robert Plenge | M | 53 | 5 Jahre | |
| Heather Adams | F | - | 4 Jahre | |
| Abed Al-Nasser Odeh | M | - | - | |
| Tim Power | M | - | 18 Jahre | |
| Teresa Foy | M | 60 | 5 Jahre | |
| Nicole Keith | F | - | 9 Jahre | |
| Michael Barrett | M | 81 |
Cardioxyl Pharmaceuticals LLC
Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | - |
| Andrew Partridge | M | 55 | 4 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Andrew Miller | M | 42 | 15 Jahre | |
| Giovanni Caforio | M | 59 | 24 Jahre | |
| Steven Paul | M | 73 | 6 Jahre | |
| Lamberto Andreotti | M | 73 | 19 Jahre | |
| Charles Baum | M | 65 | 12 Jahre | |
| Peter R. Dolan | M | 68 | 18 Jahre | |
| Carol Gallagher | M | 59 | 5 Jahre | |
| James Cornelius | M | 81 | 10 Jahre | |
| William Meury | M | 56 | 1 Jahre | |
| Kenneth Song | M | 49 | 4 Jahre | |
| Thomas Lynch | M | 63 | 5 Jahre | |
| Christopher Coughlin | M | 71 | 4 Jahre | |
| Faheem Hasnain | M | 65 | 8 Jahre | |
| Garry Nicholson | M | 69 | 2 Jahre | |
| John E. Celentano | M | 64 | 31 Jahre | |
| John E. Elicker | M | 64 | 20 Jahre | |
| Fouad Namouni | M | 55 | 21 Jahre | |
| Charles Bancroft | M | 65 | 36 Jahre | |
| Douglas Manion | M | 64 | 11 Jahre | |
| Jason Haddock | M | 54 | 14 Jahre | |
| Aaron Davis | M | 45 | 6 Jahre | |
| John Tsai | M | 57 | 11 Jahre | |
| Gerald Storch | M | 67 | 12 Jahre | |
| David J. Helfgott | M | - | - | |
| Michael Bonney | M | 65 | 2 Jahre | |
| Togo Dennis West | M | 81 | 10 Jahre | |
| Vicki Sato | M | 75 | 15 Jahre | |
| Leif Valdemar Johansson | M | 73 | 13 Jahre | |
| Laurie Glimcher | M | 72 | 20 Jahre | |
| Louis Gerstner | M | - | - | |
| James Robinson | M | 88 | 29 Jahre | |
| Laurie Olson | F | 61 | 4 Jahre | |
| Barry J. Wolfenson | M | 57 | 23 Jahre | |
| Anthony Hooper | M | 69 | 15 Jahre | |
| Robert Bertolini | M | 61 | 4 Jahre | |
| Charles Sigal | M | 72 | 16 Jahre | |
| Harrison Bains | M | 80 | 16 Jahre | |
| Mia Kelley | F | - | 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 98 | 98,99% |
| Kanada | 1 | 1,01% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Kimberly McCutcheon Jablonski
- Persönliches Netzwerk
